CDC: Few Insured Patients With Hepatitis C Get Timely Treatment
(MedPage Today) -- Although hepatitis C infection is a highly curable disease, few insured patients diagnosed received direct-acting antiviral (DAA) treatment during 2019-2020, while disparities contributed to treatment delays, according to new...
Read more »